10 Biggest Price Target Changes For Wednesday
August 11, 8:01 AM
Rosenblatt raised Coinbase Global, Inc. (NASDAQ: COIN) price target from $400 to $420. Coinbase shares rose 2.2% to $275.51 in pre-market trading.
JP Morgan Downgrades Talis Biomedical to Neutral, Lowers Price Target to $10
August 11, 6:20 AM
JP Morgan downgrades Talis Biomedical (NASDAQ:TLIS) from Overweight to Neutral and lowers the price target from $17 to $10.
Talis Biomedical Q2 EPS $(2.51) Misses $(0.91) Estimate
August 10, 4:31 PM
Talis Biomedical (NASDAQ:TLIS) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $(0.91) by 175.82 percent.
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck’s Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 7:55 AM
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 9)
Earnings Scheduled For August 10, 2021
August 10, 4:05 AM
Companies Reporting Before The Bell
• Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 8, 10:03 AM
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 6, 7:42 AM
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 5)
Stocks That Hit 52-Week Lows On Thursday
August 5, 10:05 AM
During Thursday's morning session, 77 companies made new 52-week lows.
62 Biggest Movers From Yesterday
July 21, 4:43 AM
Gainers
NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment of fibromyalgia with its wearable neurostimulation technology.